All Stories

  1. Sulphur Analogues of Homoisoflavonoids as Potential Treatments for Neovascular Eye Diseases
  2. Emulsion and Emulgel-Based Ophthalmic Drug Delivery Systems
  3. Angiogenesis Signaling in Retinoblastoma: Prognostic and Therapeutic Applications
  4. Long-term Dietary Fat Intervention Affects Retinal Health in APOE Mice
  5. Nanovesicular ultra-deformable transferosomes and transgelosomes for ocular drug delivery
  6. Exploring the Antiangiogenic and Anti-Inflammatory Potential of Homoisoflavonoids: Target Identification Using Biotin Probes
  7. Long‐Acting Microparticle Formulation of Griseofulvin for Ocular Neovascularization Therapy
  8. Beyond VEGF: Targeting Inflammation and Other Pathways for Treatment of Retinal Disease
  9. Antiangiogenic Pterocarpan and Flavonoid Constituents of Erythrina lysistemon
  10. Identification of Novel Pathways Regulated by APE1/Ref-1 in Human Retinal Endothelial Cells
  11. Synthesis and Structure Revision of Naturally Occurring Homoisoflavane (+)-Dracaeconolide B
  12. Decreased Expression of Soluble Epoxide Hydrolase Suppresses Murine Choroidal Neovascularization
  13. Mouse Pharmacokinetics and In Vitro Metabolism of SH-11037 and SH-11008, Synthetic Homoisoflavonoids for Retinal Neovascularization
  14. An improved method for murine laser-induced choroidal neovascularization lesion quantification from optical coherence tomography images
  15. Inhibition of APE1/Ref-1 for Neovascular Eye Diseases: From Biology to Therapy
  16. Measurement of mitochondrial respiration in the murine retina using a Seahorse extracellular flux analyzer
  17. NF-κB Signaling Is Regulated by Fucosylation in Metastatic Breast Cancer Cells
  18. Building a virtual summer research experience in cancer for high school and early undergraduate students: lessons from the COVID-19 pandemic
  19. Cancer Research in the “Chemical Biology” Section of the Journal Molecules
  20. Heme Synthesis Inhibition Blocks Angiogenesis via Mitochondrial Dysfunction
  21. Pharmacological Potential of Small Molecules for Treating Corneal Neovascularization
  22. Ferrochelatase regulates retinal neovascularization
  23. Mitochondrial Heme Synthesis Enzymes as Therapeutic Targets in Vascular Diseases
  24. Ferrochelatase regulates retinal neovascularization
  25. Total Synthesis of Naturally Occurring 5,7,8-Trioxygenated Homoisoflavonoids
  26. Heme synthesis inhibition blocks angiogenesis via mitochondrial dysfunction
  27. Observations on spontaneous tumor formation in mice overexpressing mitotic kinesin Kif14
  28. Small molecules inhibit ex vivo tumor growth in bone
  29. Ref-1/APE1 Inhibition with Novel Small Molecules Blocks Ocular Neovascularization
  30. Retinoblastoma, the visible CNS tumor: A review
  31. Ferrochelatase is a therapeutic target for ocular neovascularization
  32. Design, synthesis and biological evaluation of photoaffinity probes of antiangiogenic homoisoflavonoids
  33. Synthesis of Natural Homoisoflavonoids Having Either 5,7-Dihydroxy-6-methoxy or 7-Hydroxy-5,6-dimethoxy Groups
  34. Molecular analysis distinguishes metastatic disease from second cancers in patients with retinoblastoma
  35. Kif14overexpression accelerates murine retinoblastoma development
  36. A novel small molecule ameliorates ocular neovascularisation and synergises with anti-VEGF therapy
  37. A Simple Optical Coherence Tomography Quantification Method for Choroidal Neovascularization
  38. Retinoblastoma
  39. Synthesis and Biological Evaluation of Novel Homoisoflavonoids for Retinal Neovascularization
  40. Cancer Genetics Education in a Low- to Middle-Income Country: Evaluation of an Interactive Workshop for Clinicians in Kenya
  41. Kif14: A Clinically Relevant Kinesin and Potential Target for Cancer Therapy
  42. Natural product inhibitors of ocular angiogenesis
  43. Primary cilia signaling mediates intraocular pressure sensation
  44. Multimodality Imaging Methods for Assessing Retinoblastoma Orthotopic Xenograft Growth and Development
  45. Synthesis and Mechanistic Studies of a Novel Homoisoflavanone Inhibitor of Endothelial Cell Growth
  46. Transcriptional and Epigenetic Regulation of KIF14 Overexpression in Ovarian Cancer
  47. KIF14 Promotes AKT Phosphorylation and Contributes to Chemoresistance in Triple-Negative Breast Cancer
  48. The first synthesis of the antiangiogenic homoisoflavanone, cremastranone
  49. The genomic landscape of retinoblastoma: a review
  50. Posttranslational protein knockdown coupled to receptor tyrosine kinase activation with phosphoPROTACs
  51. Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies
  52. KIF14 as an oncogene in retinoblastoma: a target for novel therapeutics?
  53. Retinoblastoma tumorigenesis: genetic and epigenetic changes walk hand in hand
  54. Author Response: Does the Time of Inactivation of pRb Determine the Cell of Origin of Retinoblastoma?
  55. The TAg-RB Murine Retinoblastoma Cell of Origin Has Immunohistochemical Features of Differentiated Müller Glia with Progenitor Properties
  56. Small-molecule hydrophobic tagging–induced degradation of HaloTag fusion proteins
  57. Triptolide Directly Inhibits dCTP Pyrophosphatase
  58. HIV Protease-Mediated Activation of Sterically Capped Proteasome Inhibitors and Substrates
  59. Bcl-2 SNP rs956572 associates with disrupted intracellular calcium homeostasis in bipolar I disorder
  60. Design and Applications of Bifunctional Small Molecules: Why Two Heads Are Better Than One
  61. Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastoma
  62. Using expression profiling data to identify human microRNA targets
  63. High Expression ofKIF14in Retinoblastoma: Association with Older Age at Diagnosis
  64. Molecular Understanding and Modern Application of Traditional Medicines: Triumphs and Trials
  65. KIF14 Messenger RNA Expression Is Independently Prognostic for Outcome in Lung Cancer
  66. One hit, two hits, three hits, more? Genomic changes in the development of retinoblastoma
  67. Profiling genomic copy number changes in retinoblastoma beyond loss ofRB1
  68. KIF14 mRNA expression is a predictor of grade and outcome in breast cancer
  69. Distinct patterns of expression of the RB gene family in mouse and human retina
  70. KIF14 is a candidate oncogene in the 1q minimal region of genomic gain in multiple cancers
  71. Cell-type specific regulation of calreticulin and Bcl-2 expression by mood stabilizer drugs
  72. Chronic Lithium Treatment Attenuates Intracellular Calcium Mobilization
  73. Association analysis of G-protein β3 subunit gene with altered Ca2+ homeostasis in bipolar disorder